Page last updated: 2024-11-05

troglitazone and Anorexia

troglitazone has been researched along with Anorexia in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.

Research Excerpts

ExcerptRelevanceReference
"Recently, we found that profound anorexia observed in a catabolic model induced by chronic glucocorticoid (dexamethasone, Dex) injection could be associated with strong hyperleptinemia."3.73Troglitazone reduces leptinemia during experimental dexamethasone-induced stress. ( Caldefie-Chézet, F; Enreille-Leger, A; Poulin, A; Vasson, MP, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caldefie-Chézet, F1
Poulin, A1
Enreille-Leger, A1
Vasson, MP1

Other Studies

1 other study available for troglitazone and Anorexia

ArticleYear
Troglitazone reduces leptinemia during experimental dexamethasone-induced stress.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2005, Volume: 37, Issue:3

    Topics: Adipocytes; Adipose Tissue; Animals; Anorexia; Blood Glucose; Body Weight; Chemical and Drug Induced

2005